Articles by James Calloway
Timken Stock Climbs After Insider Sale, Earnings Outlook Boost
Timken shares rose 1% to $131.56 after a director's $1.73 million sale, while raised 2026 adjusted EPS guidance and strong Q2 results support the stock's upside.
Starbucks Shares Near Record High as Unicorn Frappuccino Drives Traffic, Not Profit
Starbucks reintroduces its Unicorn Frappuccino for a weekend, aiming to drive foot traffic as shares hover near record highs. Q3 transactions rose 4.2%, but the drink's direct revenue impact is small.
Oreo Vote Tests Mondelez's North American Volume Recovery
Mondelez's Oreo flavor vote will test whether North American volume growth can hold after a 1.6-point sequential improvement in Q2.
CoreWeave Holds Gains Post-Earnings as $104B Backlog Strains Capital
CoreWeave shares hold post-earnings gains despite a $104.2B backlog and heavy capex, with analysts split on valuation and capital efficiency concerns.
Cellebrite Plunges 31% on Missed ARR, CEO Change
Cellebrite shares dropped 31% as Q2 ARR fell short and the company cut its full-year guidance. CEO Shiven Ramji took over immediately.
American Airlines Overhauls Leadership to Close Profitability Gap with Delta
American Airlines reshuffles senior leadership to tackle a wide profit margin gap versus Delta and United. Q2 earnings per $100 revenue were $0.43 vs Delta's $8.08. Shares rose 0.8%.
Intuitive Machines Tumbles as Q2 Misses, H2 Growth Hurdle Looms
Intuitive Machines stock dropped 8.6% premarket after Q2 revenue missed forecasts and adjusted EBITDA swung to a loss. The company's full-year outlook requires a sharp acceleration in H2 revenue growth.
FGI Industries Stock Soars 186% on Q2 Profit Recovery
FGI Industries shares surged 186% after Q2 profit recovery, with gross margin up 5.3 points. Revenue rose 2.9% to $31.9 million, but the stock's valuation now outstrips full-year guidance.
NYT's Puzzle Push: Subscriber Growth Target Faces Headwinds
New York Times (NYT) must add ~275,000 subscribers quarterly to reach its 2027 goal. Recent Games search interest offers hope, but Q2 growth barely met the pace.
Birkenstock Shares Surge 17% on Upbeat Revenue Forecast
Birkenstock (BIRK) shares soared 17% on Thursday after the company raised its annual sales growth outlook, overshadowing a small earnings miss.
Eli Lilly Defends Obesity Drug Pipeline Amid Retatrutide Lawsuits
Eli Lilly shares rose 0.5% as the company filed six lawsuits against unauthorized sellers of its experimental obesity drug retatrutide, reinforcing its commitment to pipeline integrity.
EnerSys Surges 15% on Q1 Earnings Blowout
EnerSys (ENS) shares soared 15% premarket after Q1 adjusted EPS of $3.66 crushed estimates, though revenue only edged up 4.8%.